Gene · 2826
Papers2,000
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,000
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Blockade of CCR4 breaks immune tolerance in chronic hepatitis B patients by modulating regulatory pathways. | J Transl Med | 2023 | 37081509 | PubTator, text mining | PubMed |
Plasmablasts in previously immunologically naïve COVID-19 patients express markers indicating mucosal homing and secrete antibodies cross-reacting with SARS-CoV-2 variants and other beta-coronaviruses. | Clin Exp Immunol | 2023 | 37071584 | PubTator, text mining | PubMed |
| Targeting tumor immunosuppressive microenvironment for pancreatic cancer immunotherapy: Current research and future perspective. | Front Oncol | 2023 | 37064113 | PubTator, text mining | PubMed |
| Comprehensive analysis reveals CCDC60 as a potential biomarker correlated with prognosis and immune infiltration of head and neck squamous cell carcinoma. | Front Oncol | 2023 | 37064086 | PubTator, text mining | PubMed |
| New insights into the immune functions of podocytes: the role of complement. | Mol Cell Pediatr | 2023 | 37059832 | PubTator, text mining | PubMed |
| Potential treatments of COVID-19: Drug repurposing and therapeutic interventions. | J Pharmacol Sci | 2023 | 37059487 | PubTator, text mining | PubMed |
| Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma. | Blood Adv | 2023 | 37058474 | PubTator, text mining | PubMed |
| Dapsone hypersensitivity syndrome. | Chin Med J (Engl) | 2023 | 37057725 | PubTator, text mining | PubMed |
| Enhancement of immune surveillance in breast cancer by targeting hypoxic tumor endothelium: Can it be an immunological switch point? | Front Oncol | 2023 | 37056346 | PubTator, text mining | PubMed |
| The Role of Cytokines in Cholesterol Accumulation in Cells and Atherosclerosis Progression. | Int J Mol Sci | 2023 | 37047399 | PubTator, text mining | PubMed |
| Promises and challenges of mucosal COVID-19 vaccines. | Vaccine | 2023 | 37045682 | PubTator, text mining | PubMed |
| Systematic pan-cancer analysis of the potential tumor diagnosis and prognosis biomarker P4HA3. | Front Genet | 2023 | 37035741 | PubTator, text mining | PubMed |
| Immune Profiling Reveals Decreases in Circulating Regulatory and Exhausted T Cells in Human Hypertension. | JACC Basic Transl Sci | 2023 | 37034287 | PubTator, text mining | PubMed |
| Advances and potential of omics studies for understanding the development of food allergy. | Front Allergy | 2023 | 37034151 | PubTator, text mining | PubMed |
| Blocking CCR10 Expression Activates m6A Methylation and Alleviates Vascular Endothelial Cell Injury. | Discov Med | 2023 | 37024440 | PubTator, text mining | PubMed |
| Parallel recovery of chromatin accessibility and gene expression dynamics from frozen human regulatory T cells. | Sci Rep | 2023 | 37016052 | PubTator, text mining | PubMed |
| Comprehensive Explorations of CCL28 in Lung Adenocarcinoma Immunotherapy and Experimental Validation. | J Inflamm Res | 2023 | 37006812 | PubTator, text mining | PubMed |
| Allergen sensitization stratifies IL-31 production by memory T cells in atopic dermatitis patients. | Front Immunol | 2023 | 36993985 | PubTator, text mining | PubMed |
| The Role of Different Immunocompetent Cell Populations in the Pathogenesis of Head and Neck Cancer-Regulatory Mechanisms of Pro- and Anti-Cancer Activity and Their Impact on Immunotherapy. | Cancers (Basel) | 2023 | 36980527 | PubTator, text mining | PubMed |
| Streptavidin-Saporin: Converting Biotinylated Materials into Targeted Toxins. | Toxins (Basel) | 2023 | 36977072 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2826/papers?page=12